Feldman named chief of breast surgery & surgical oncology, director of breast cancer services at Montefiore and Einstein

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Sheldon M. Feldman was named chief of the division of breast surgery and surgical oncology, and director of Breast Cancer Services at Montefiore Einstein Center for Cancer Care, the clinical arm of the Albert Einstein Cancer Center.

Feldman will also join the faculty of Albert Einstein College of Medicine as a professor of clinical surgery. Feldman has pioneered techniques such as intraoperative radiation. He is also an innovator in reducing risk of lymphedema. Feldman is the president of the American Society of Breast Surgeons.

Feldman is the former chief of the breast surgery division at New York-Presbyterian Hospital/ Columbia University Medical Center and as the Vivian L. Milstein Associate Professor of Clinical Surgery. Feldman will serve as a principle investigator on multiple breast cancer studies focused on advancing prevention, early diagnosis and patient centered treatment of the disease.

Table of Contents

YOU MAY BE INTERESTED IN

The Trump administration did exactly what it said it would do to disorient anyone involved in making policy or touched by it. The president and his crew have “flooded the zone”—the term and the image are theirs, as is the strategy of dropping a flurry of executive orders and memoranda that shake the foundations of the American system of government, raising questions of legality and constitutionality, and, above all, making it a challenge for anyone to see the entire picture and think strategically.
In two raucous back-to-back hearings on Jan. 29 and Jan. 30, anti-vaccine crusader Robert F. Kennedy Jr. was grilled by members of the United States Senate Finance Committee and the Health, Education, Labor, and Pensions Committee as the Trump administration seeks his confirmation as secretary of the Department of Health and Human Services. 
Over the past century, groundbreaking cancer research in the U.S. has led to life-saving medical advances that benefit patients worldwide. Scientists often devote their lives to making discoveries, putting their scientific endeavors ahead of status, income, or lifestyle. Investigators work tirelessly, often seven days a week, to solve complex medical problems. These efforts often lead to game-changing outcomes that help us understand difficult medical challenges, advance technologies and develop new therapies. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login